| DNA lentivector for transduction information: |
GENTAUR suggests to use our ABM packaging mix LV003 of second generation virusses or the LV053, This DNA can alos be used for packaging into Lentiviral particles for high efficiency transduction and stably integrated expressions, Vectors with selection markers like kanamycin, our 3rd Generation Packaging mixture, pLenti lentiviral plasmids DNAs are stored in 10milliMolar Tris/HCI with 1mM EDTA at a pH of 8 at -25 C, puromycin or cumate are available, Lentiveral packaging plasmid DNA for non-viral plasmid transfection and direct use in plasmid expression |
| Properties: |
Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine, , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp |
| Gene target: |
A2M Lentiviral Vector (CMV) (pLenti-GIII-CMV-C-term-HA) |
| Short name: |
A2M Lentiviral Vector ( ) (CMV) (pLenti-GIII-CMV-C-term-HA) |
| Technique: |
Vectors |
| Species: |
Humans, Human |
| Alternative name: |
sapiens) (cytomegalovirus) (pLenti-GIII-cytomegalovirus-c terminus-HA), alpha-2-macroglobulin Lentiviral integrating Desoxyribonucleic acid sequence (H |
| Alternative to gene target: |
A2M and IDBG-17623 and ENSG00000175899 and 2, A2M and IDBG-639675 and ENSBTAG00000018137 and 513856, A2MD and CPAMD5 and FWP007 and S863-7, A2m and IDBG-184734 and ENSMUSG00000030111 and 232345, Extracellular, calcium-dependent protein binding, intrinsic pathway and biological process this GO :0010951 and negative regulation of endopeptidase activity and biological process this GO :0019838 and growth factor binding and molecular function this GO :0019899 and enzyme binding and molecular function this GO :0019959 and interleukin-8 binding and molecular function this GO :0019966 and interleukin-1 binding and molecular function this GO :0022617 and extracellular matrix disassembly and biological process this GO :0030168 and platelet activation and biological process this GO :0030198 and extracellular matrix organization and biological process this GO :0031093 and platelet alpha granule lumen and cellular component this GO :0043120 and tumor necrosis factor binding and molecular function this GO :0048306 and calcium-dependent protein binding and molecular function this GO :0048863 and stem cell differentiation and biological process this GO :0051056 and regulation of small GTPase mediated signal transduction and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0072562 and blood microparticle and cellular component, lectin pathway and biological process this GO :0002020 and protease binding and molecular function this GO :0002576 and platelet degranulation and biological process this GO :0004866 and endopeptidase inhibitor activity and molecular function this GO :0004867 and serine-type endopeptidase inhibitor activity and molecular function this GO :0005102 and receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005829 and cytosol and cellular component this GO :0007264 and small GTPase mediated signal transduction and biological process this GO :0007596 and blood coagulation and biological process this GO :0007597 and blood coagulation, this GO :0001869 and negative regulation of complement activation, this GO :0002020 : protease binding, this GO :0002020 : protease binding and also this GO :0004866 : endopeptidase inhibitor activity and also this GO :0004867 : serine-type endopeptidase inhibitor activity and also this GO :0005102 : receptor binding and also this GO :0005515 : protein binding and also this GO :0019838 : growth factor binding and also this GO :0019899 : enzyme binding and also this GO :0019959 : interleukin-8 binding and also this GO :0019966 : interleukin-1 binding and also this GO :0043120 : tumor necrosis factor binding and also this GO :0048306 : calcium-dependent protein binding, this GO :0004866 : endopeptidase inhibitor activity, this GO :0004867 : serine-type endopeptidase inhibitor activity, this GO :0005102 : receptor binding, this GO :0005515 : protein binding, this GO :0019838 : growth factor binding, this GO :0019899 : enzyme binding, this GO :0019959 : interleukin-8 binding, this GO :0019966 : interleukin-1 binding, this GO :0043120 : tumor necrosis factor binding, this GO :0048306 : calcium-dependent protein binding, alpha-2-macroglobulin |
| Identity: |
7 |
| Gene: |
A2M |
More about : A2M |
| Long gene name: |
alpha-2-macroglobulin |
| Synonyms: |
FWP007 S863-7 CPAMD5 |
| Locus: |
12p13, 31 |
| Discovery year: |
1986-01-01 |
| GenBank acession: |
BX647329 X68728 M11313 |
| Entrez gene record: |
2 |
| Pubmed identfication: |
2408344 9697696 |
| RefSeq identity: |
NM_000014 |
| Classification: |
C3 and PZP like, alpha-2-macroglobulin domain containing |
| Havana BLAST/BLAT: |
OTTHUMG00000150267 |